Euro watchdogs intensify antitrust probe

The big antitrust investigation going on in Europe is just getting bigger. Watchdogs have started questioning distribution companies, trade groups, trading companies, and others.

Some who received questionnaires said the queries zeroed in on drugmakers' activities vis-a-vis parallel trade. Antitrust investigators want to know whether pharma is trying to quash those deals, under which wholesalers or trading companies buy meds in markets where they're cheap and resell them in countries where they're more expensive. The questionnaires also asked about direct-to-pharmacy distribution deals like those recently inked by Pfizer and AstraZeneca.

- read the Wall Street Journal story

Reltaed Articles:
EU commissioner widens pharma probe
U.K. assails Pfizer-type distribution
AZ preps for UK distribution switch

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.